Z. B. Kaya Et Al. , "Post-inflammatory administration of N-acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease," FASEB BioAdvances , vol.5, no.7, pp.263-276, 2023
Kaya, Z. B. Et Al. 2023. Post-inflammatory administration of N-acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease. FASEB BioAdvances , vol.5, no.7 , 263-276.
Kaya, Z. B., KARAKOÇ, E., McLean, P. J., Saka, E., & ATİLLA, P., (2023). Post-inflammatory administration of N-acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease. FASEB BioAdvances , vol.5, no.7, 263-276.
Kaya, ZEYNEP Et Al. "Post-inflammatory administration of N-acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease," FASEB BioAdvances , vol.5, no.7, 263-276, 2023
Kaya, ZEYNEP B. Et Al. "Post-inflammatory administration of N-acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease." FASEB BioAdvances , vol.5, no.7, pp.263-276, 2023
Kaya, Z. B. Et Al. (2023) . "Post-inflammatory administration of N-acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease." FASEB BioAdvances , vol.5, no.7, pp.263-276.
@article{article, author={ZEYNEP BENGİSU KAYA Et Al. }, title={Post-inflammatory administration of N-acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease}, journal={FASEB BioAdvances}, year=2023, pages={263-276} }